CLINICAL_TRIALS
trial_result
· 2013-02-04
Clinical Trial Update: Safety Study of JTT-302 in Subjects With Low HDL-C Levels [Phase 2]
Summary
The document notes the completion of a Phase 2 safety study of JTT-302 in people with low HDL cholesterol.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Akros Pharma Inc. | Conditions: Dyslipidemia | Phase 2 | Status: COMPLETED